UniProt P14780
Matrix metalloproteinase-9,Matrix metalloproteinase-9 (P14780)
Matrix metalloproteinase-9,Matrix metalloproteinase-9 (UniProt P14780), EC 3.4.24.35: 51 experimental structures and 1 predicted model on GenesisL1, 12 ligands bound, 42 pockets. Binding sites, druggability and experiment against…
- UniProt
- P14780
- Protein
- Matrix metalloproteinase-9,Matrix metalloproteinase-9
- EC
- 3.4.24.35
- Experimental structures
- 51
- Predicted models
- 1
- Ligands
- 12
- Pockets
- 42 · 4 records with a druggable one
Structures
52 records of P14780 in the MolNFT archive: 51 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1GKC | MMP9-inhibitor complex | x-ray diffraction | A, B | — | — |
| 1GKC | MMP9-inhibitor complex | x-ray diffraction | A, B | — | — |
| 1GKD | MMP9 active site mutant-inhibitor complex | x-ray diffraction | A, B | — | — |
| 1GKD | MMP9 active site mutant-inhibitor complex | x-ray diffraction | A, B | — | — |
| 1ITV | Dimeric form of the haemopexin domain of MMP9 | x-ray diffraction | A, B | — | — |
| 1ITV | Dimeric form of the haemopexin domain of MMP9 | x-ray diffraction | A, B | — | — |
| 1L6J | Crystal structure of human matrix metalloproteinase MMP9 (gelatinase B). | x-ray diffraction | A | — | — |
| 1L6J | Crystal structure of human matrix metalloproteinase MMP9 (gelatinase B). | x-ray diffraction | A | — | — |
| 2OVX | MMP-9 active site mutant with barbiturate inhibitor | x-ray diffraction | A, B | — | — |
| 2OVX | Mmp-9 active site mutant with barbiturate inhibitor | x-ray diffraction | A, B | — | — |
| 2OVZ | MMP-9 active site mutant with phosphinate inhibitor | x-ray diffraction | A, B | — | — |
| 2OVZ | Mmp-9 active site mutant with phosphinate inhibitor | x-ray diffraction | A, B | — | — |
| 2OW0 | MMP-9 active site mutant with iodine-labeled carboxylate inhibitor | x-ray diffraction | A, B | — | — |
| 2OW0 | Mmp-9 active site mutant with iodine-labeled carboxylate inhibitor | x-ray diffraction | A, B | — | — |
| 2OW1 | MMP-9 active site mutant with trifluoromethyl hydroxamate inhibitor | x-ray diffraction | A, B | — | — |
| 2OW1 | Mmp-9 active site mutant with trifluoromethyl hydroxamate inhibitor | x-ray diffraction | A, B | — | — |
| 2OW2 | MMP-9 active site mutant with difluoro butanoic acid inhibitor | x-ray diffraction | A, B | — | — |
| 2OW2 | Mmp-9 active site mutant with difluoro butanoic acid inhibitor | x-ray diffraction | A, B | — | — |
| 4H1Q | Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor. | x-ray diffraction | A, B | — | — |
| 4H1Q | Crystal structure of mutant mmp-9 catalytic domain in complex with a twin inhibitor. | x-ray diffraction | A, B | — | — |
| 4H2E | Crystal structure of an MMP twin inhibitor complexing two MMP-9 catalytic domains | x-ray diffraction | A, B | — | — |
| 4H2E | Crystal structure of an mmp twin inhibitor complexing two mmp-9 catalytic domains | x-ray diffraction | A, B | — | — |
| 4H3X | Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the… | x-ray diffraction | A, B | — | — |
| 4H3X | Crystal structure of an mmp broad spectrum hydroxamate based inhibitor CC27 in complex with the… | x-ray diffraction | A, B | — | — |
| 4H82 | Crystal structure of mutant MMP-9 catalytic domain in complex with a twin inhibitor. | x-ray diffraction | A, B, C, D | — | — |
| 4H82 | Crystal structure of mutant mmp-9 catalytic domain in complex with a twin inhibitor. | x-ray diffraction | A, B, C, D | — | — |
| 4HMA | Crystal structure of an MMP twin carboxylate based inhibitor LC20 in complex with the MMP-9… | x-ray diffraction | A, B | — | — |
| 4HMA | Crystal structure of an mmp twin carboxylate based inhibitor LC20 in complex with the mmp-9… | x-ray diffraction | A, B | — | — |
| 4JIJ | Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic… | x-ray diffraction | A, B | — | — |
| 4JIJ | Crystal structure of an inactive mutant of mmp-9 catalytic domain in complex with a fluorogenic… | x-ray diffraction | A, B | — | — |
| 4JQG | Crystal structure of an inactive mutant of MMP-9 catalytic domain in complex with a fluorogenic… | x-ray diffraction | A, B | — | — |
| 4JQG | Crystal structure of an inactive mutant of mmp-9 catalytic domain in complex with a fluorogenic… | x-ray diffraction | A, B | — | — |
| 4WZV | Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain | x-ray diffraction | A, B | — | — |
| 4WZV | Crystal structure of a hydroxamate based inhibitor EN140 in complex with the mmp-9 catalytic domain | x-ray diffraction | A, B | — | — |
| 4XCT | Crystal structure of a hydroxamate based inhibitor ARP101 (EN73) in complex with the MMP-9… | x-ray diffraction | A | — | — |
| 4XCT | Crystal structure of a hydroxamate based inhibitor ARP101 (EN73) in complex with the mmp-9… | x-ray diffraction | A | — | — |
| 5CUH | Crystal structure MMP-9 complexes with a constrained hydroxamate based inhibitor LT4 | x-ray diffraction | A, B | ZN, CA, LTQ | — |
| 5CUH | Crystal structure mmp-9 complexes with a constrained hydroxamate based inhibitor LT4 | x-ray diffraction | A, B | — | — |
| 5I12 | Crystal structure of the catalytic domain of MMP-9 in complex with a selective sugar-conjugated… | x-ray diffraction | A | ZN, CA, H27 | — |
| 5I12 | Crystal structure of the catalytic domain of mmp-9 in complex with a selective sugar-conjugated… | x-ray diffraction | A | — | — |
| 5TH6 | Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9) | x-ray diffraction | A, B, C, D | ZN, CA | 11 (best 0.71) |
| 5TH6 | Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9) | x-ray diffraction | A, B, C, D | ZN, CA | — |
| 5TH9 | Structure determination of a potent, selective antibody inhibitor of human MMP9 (GS-5745 bound to… | x-ray diffraction | A, B, C | ZN, CA, NCO | 13 (best 0.72) |
| 5TH9 | Structure determination of a potent, selective antibody inhibitor of human MMP9 (gs-5745 bound to… | x-ray diffraction | A, B, C | ZN, CA, NCO | — |
| 5UE3 | proMMP-9desFnII | x-ray diffraction | A, B | ZN, CA, SO4 | — |
| 5UE3 | Prommp-9DESFNII | x-ray diffraction | A, B | ZN, CA, SO4 | — |
| 5UE4 | proMMP-9desFnII complexed to JNJ0966 INHIBITOR | x-ray diffraction | A, B | ZN, CA, SO4, 5XQ | — |
| 5UE4 | Prommp-9DESFNII complexed to JNJ0966 inhibitor | x-ray diffraction | A, B | ZN, CA, SO4, 5XQ | — |
| 6ESM | Crystal structure of MMP9 in complex with inhibitor BE4. | x-ray diffraction | A | ZN, CA, B9Z, PZE | — |
| 8K5V | Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | x-ray diffraction | A, B | ZN, CA, VOC, 2HP | 9 (best 0.72) |
| 8K5W | Crystal structure of human proMMP-9 catalytic domain in complex with inhibitor | x-ray diffraction | A, B | ZN, CA, VOO, 2HP | 9 (best 0.72) |
| P14780 | AlphaFold monomer V2.0 prediction for matrix metalloproteinase-9 (P14780) | predicted | A | — | — |
Ligands
- CA · Calcium ion · in 13 records
- ZN · Zinc ion · in 13 records
- SO4 · Sulfate ion · in 4 records
- 2HP · Dihydrogenphosphate ion · in 2 records
- 5XQ · ~{N}-[5-[2-[(2-methoxyphenyl)amino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]ethanamide · in 2 records
- NCO · Cobalt hexammine(iii) · in 2 records
- B9Z · (2~{S})-2-[2-[4-(4-methoxyphenyl) phenyl]sulfanylphenyl]pentanedioic acid · in 1 record
- H27 · (2R)-2-[{(E)-2-[({(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]tetrahydro-2H-pyran-2-yl}carbamothioyl)amino]ethenyl}(biphenyl-4-ylsulfonyl)amino]-3-methylbutanoic acid · in 1 record
- LTQ · (4S)-3-{[4-(4-cyano-2-methylphenyl)piperazin-1-yl]sulfonyl}-N-hydroxy-1,3-thiazolidine-4-carboxamide · in 1 record
- PZE · piperazine · in 1 record
- VOC · 6,7-dihydro-4H-[1,3]oxazolo[4,5-c]pyridin-5-yl-(7-ethyl-2H-indazol-3-yl)methanone · in 1 record
- VOO · 2-[[5-fluoranyl-7-(methylamino)-1H-indol-2-yl]carbonyl]-N-(2-pyrrol-1-ylethyl)-3,4-dihydro-1H-isoquinoline-7-carboxamide · in 1 record
Experiment against prediction
- 4XCT chain A against the predicted model P14780: TM-score 0.98, RMSD 0.63 Å
- 4XCT chain A against the predicted model P14780: TM-score 0.98, RMSD 0.63 Å
- 5I12 chain A against the predicted model P14780: TM-score 0.98, RMSD 0.63 Å
- 5I12 chain A against the predicted model P14780: TM-score 0.98, RMSD 0.63 Å
- 6ESM chain A against the predicted model P14780: TM-score 0.98, RMSD 0.69 Å
- 2OW1 chain B against the predicted model P14780: TM-score 0.98, RMSD 0.68 Å
- 2OW1 chain B against the predicted model P14780: TM-score 0.98, RMSD 0.68 Å
- 2OW2 chain A against the predicted model P14780: TM-score 0.98, RMSD 0.76 Å
- 2OW2 chain A against the predicted model P14780: TM-score 0.98, RMSD 0.76 Å
- 8K5W chain B against the predicted model P14780: TM-score 0.98, RMSD 0.81 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.